University of South Florida

Arizona State University

Microdosing is the administration of a psychedelic drug/medication at one-tenth of the dose that would cause hallucinogenic effects.

Microdosing

Sugiyama, Y., &amp; Yamashita, S. (2010, October 13). Impact of microdosing clinical study - why necessary and how useful? Advanced Drug Delivery Reviews. Retrieved May 8, 2022, from https://www.sciencedirect.com/science/article/pii/S0169409X10001882?casa_token=XSqoYLXdROgAAAAA%3ABCJiV392UsdSpr9V7J5agHkhpncwNIPuDOW0XA814eAqKchOcEzyGMTPbVl-p-ttHuuKBCgxAoxB 

Impact of Microdosing Clinical Study - why and how useful?

Psychedelics, in particular LSD and psilocybin, have been investigated as potential treatments for depressive symptoms. There is evidence for short-, medium-, and long-term usefulness in both micro-dosing and regular studies. In addition to the potential cognitive stimulation (LSD) or emotional well-being effects (psilocybin), these treatments are generally well-tolerated in clinical and general populations. In addition, MDMA has received breakthrough treatment status with the FDA for the treatment of PTSD.

Potential clinical uses for psychedelics

Impact of Microdosing clinical study -- Why necessary and how useful?
 -- Why Necessary?

It has often been claimed that psychedelics have therapeutic value in treating many types of mental health conditions such as depression. It is seen that psychedelics like LSD or psilocybin have shown subtle but positive effects on cognitive processing. Howeverm there are other side effects that are also present in the dosing of these drugs if not carefully dosed, and in lower doses. 

Learn Before

Related